Secondary-progressive Multiple Sclerosis (SPMS) trials recruiting in District of Columbia

Fewer than 3 recruiting trials found.

All Secondary-progressive Multiple Sclerosis (SPMS) trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
  NCT07225504 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · District of Columbia: Washington D.C.